🔎 Trials Near Me

Dachaigh › Myasthenia Gravis › Pennsylvania

Sgrùdaidhean clionaigeach Myasthenia Gravis ann an Pennsylvania

Tha 6 sgrùdaidhean airson Myasthenia Gravis a’ lorg phàirtichean aig làraichean ann an Pennsylvania.

Bailtean ann an Pennsylvania

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

  • The Childrens Hospital of Philadelphia, Philadelphia
A’ fastadhÌre 2
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06987539

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

  • Penn State Milton S Hershey Medical Ctr, Hershey
  • Childrens Hospital Of Philadelphia, Philadelphia
A’ fastadhÌre 2/3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT05265273

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

  • Thomas Jefferson University Hospital, Philadelphia
A’ fastadhÌre 2/3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06193889

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

  • Temple University Hospital, Philadelphia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Gearr 2026 · NCT06626919

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  • Clinical Trial Site, Philadelphia
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Gearr 2026 · NCT04202341

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

  • Thomas Jefferson University, Philadelphia
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Gibl 2025 · NCT05564936

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.